-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Breakthrough Therapy Designation to Revolution Medicines' Zoldonrasib for KRAS G12D-Mutated NSCLC

路透·01/08/2026 13:03:02

登錄查看新聞詳情